The epidemiology of community-acquired Clostridium difficile infection: a population-based study
- PMID: 22108454
- PMCID: PMC3273904
- DOI: 10.1038/ajg.2011.398
The epidemiology of community-acquired Clostridium difficile infection: a population-based study
Erratum in
- Am J Gastroenterol. 2012 Jan;107(1):150
Abstract
Objectives: Clostridium difficile infection (CDI) is a common hospital-acquired infection with increasing incidence, severity, recurrence, and associated morbidity and mortality. There are emerging data on the occurrence of CDI in nonhospitalized patients. However, there is a relative lack of community-based CDI studies, as most of the existing studies are hospital based, potentially influencing the results by referral or hospitalization bias by missing cases of community-acquired CDI.
Methods: To better understand the epidemiology of community-acquired C. difficile infection, a population-based study was conducted in Olmsted County, Minnesota, using the resources of the Rochester Epidemiology Project. Data regarding severity, treatment response, and outcomes were compared in community-acquired vs. hospital-acquired cohorts, and changes in these parameters, as well as in incidence, were assessed over the study period.
Results: Community-acquired CDI cases accounted for 41% of 385 definite CDI cases. The incidence of both community-acquired and hospital-acquired CDI increased significantly over the study period. Compared with those with hospital-acquired infection, patients with community-acquired infection were younger (median age 50 years compared with 72 years), more likely to be female (76% vs. 60%), had lower comorbidity scores, and were less likely to have severe infection (20% vs. 31%) or have been exposed to antibiotics (78% vs. 94%). There were no differences in the rates of complicated or recurrent infection in patients with community-acquired compared with hospital-acquired infection.
Conclusions: In this population-based cohort, a significant proportion of cases of CDI occurred in the community. These patients were younger and had less severe infection than those with hospital-acquired infection. Thus, reports of CDI in hospitalized patients likely underestimate the burden of disease and overestimate severity.
Conflict of interest statement
Figures



Comment in
-
Editorial: not so nosocomial anymore: the growing threat of community-acquired Clostridium difficile.Am J Gastroenterol. 2012 Jan;107(1):96-8. doi: 10.1038/ajg.2011.404. Am J Gastroenterol. 2012. PMID: 22218031
References
-
- Bartlett JG, Chang TW, Gurwith M, et al. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. New Engl J Med. 1978;298:531–534. - PubMed
-
- Kelly CP, LaMont JT. Clostridium difficile--more difficult than ever. N Engl J Med. 2008;359:1932–1940. - PubMed
-
- Khanna S, Pardi DS. The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings. Expert Rev Gastroenterol Hepatol. 2010;4:409–416. - PubMed
-
- Centers for Disease Control and Prevention. Severe Clostridium difficile-associated disease in populations previously at low risk--four states 2005. Morb Mortal Wkly Rep. 2005;54:1201–1205. - PubMed
-
- Loo VG, Poirier L, Miller MA, et al. A Predominantly Clonal Multi-Institutional Outbreak of Clostridium difficile-Associated Diarrhea with High Morbidity and Mortality. N Engl J Med. 2005;353:2442–2449. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources